Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dc Healthcare Holdings Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.36%.
Dc Healthcare Holdings Bhd (XKLS:0283) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dc Healthcare Holdings Bhd (XKLS:0283) has a ROCE % of 4.36% as of Mar. 2026.
Is Dc Healthcare Holdings Bhd's ROCE % too high?
Dc Healthcare Holdings Bhd's current ROCE % is 4.36%. The Healthcare Providers & Services industry median ROCE % is 6.64. Dc Healthcare Holdings Bhd's value of 4.36% is 34.3% below this industry median. Overall, Dc Healthcare Holdings Bhd has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dc Healthcare Holdings Bhd's ROCE % compare to HCA and THC?
Dc Healthcare Holdings Bhd's ROCE % of 4.36% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.64. Dc Healthcare Holdings Bhd's value of 4.36% is 34.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.64, based on 642 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dc Healthcare Holdings Bhd's current ROCE % of 4.36% is 34.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dc Healthcare Holdings Bhd's current ROCE % is 4.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dc Healthcare Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd (XKLS:0283) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.11 — trading 62.1% below its estimated fair value. The current ROCE % is 4.36% and 34.3% below the Healthcare Providers & Services industry median of 6.64. Dc Healthcare Holdings Bhd's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dc Healthcare Holdings Bhd (XKLS:0283), the current ROCE % is 4.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dc Healthcare Holdings Bhd (XKLS:0283) Overvalued in 2026?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.11 is trading 62.1% below its estimated GF Value™ of RM0.29.
GuruFocus considers Dc Healthcare Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:0283:
ROCE %: 4.36%
GF Value™: RM0.29 vs. price of RM0.11 (62.1% below fair value)
Industry Position: 34.3% below the Healthcare Providers & Services median
No single metric tells the full story. See the XKLS:0283 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dc Healthcare Holdings Bhd Is an investment holding company. Through its subsidiaries, the company provides Aesthetic Services specializing in Non-Invasive and minimally invasive procedures that includes laser skin rejuvenation, pigmentation and acne treatments, anti-ageing procedures, facial contouring solutions and non-invasive body sculpting. The business activities are categorized into three segments, Aesthetic Services, General Medical Services, and Sale of skincare products. The majority of revenue is derived from the Aesthetic Services segment.
61GF Score
Get the complete analysis for XKLS:0283
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0283 has been successfully added to your 
